Ferozsons Laboratories Limited (PSX:FEROZ)
308.34
-0.20 (-0.06%)
At close: Mar 27, 2025
Ferozsons Laboratories Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Revenue | 16,816 | 15,855 | 11,457 | 9,330 | 8,879 | 6,212 | Upgrade
|
Revenue Growth (YoY) | 15.84% | 38.38% | 22.80% | 5.08% | 42.93% | 7.06% | Upgrade
|
Cost of Revenue | 9,631 | 9,418 | 7,252 | 5,380 | 5,246 | 3,910 | Upgrade
|
Gross Profit | 7,185 | 6,436 | 4,206 | 3,950 | 3,633 | 2,302 | Upgrade
|
Selling, General & Admin | 5,211 | 4,605 | 3,183 | 2,641 | 2,085 | 1,705 | Upgrade
|
Other Operating Expenses | 191.44 | 241.41 | 51.41 | 79.7 | 108.11 | 54.39 | Upgrade
|
Operating Expenses | 5,404 | 4,848 | 3,256 | 2,731 | 2,193 | 1,759 | Upgrade
|
Operating Income | 1,781 | 1,589 | 949.17 | 1,219 | 1,440 | 543.27 | Upgrade
|
Interest Expense | -757.75 | -648.39 | -295.51 | -83.29 | -31.44 | -22.16 | Upgrade
|
Interest & Investment Income | 56.02 | 56.02 | 206.68 | 232.06 | 81.89 | 91.3 | Upgrade
|
Currency Exchange Gain (Loss) | 33.35 | 33.35 | -478.9 | -161.84 | 47.23 | -41.72 | Upgrade
|
Other Non Operating Income (Expenses) | -24.06 | -24.06 | -8.6 | -12.99 | -12.26 | -6.36 | Upgrade
|
EBT Excluding Unusual Items | 1,089 | 1,006 | 372.84 | 1,193 | 1,525 | 564.33 | Upgrade
|
Gain (Loss) on Sale of Investments | 56.11 | 56.11 | 12.99 | 8.69 | 2.45 | 3.83 | Upgrade
|
Gain (Loss) on Sale of Assets | 78.51 | 78.51 | 28.84 | 35.11 | 38.17 | 23.78 | Upgrade
|
Pretax Income | 1,223 | 1,140 | 414.67 | 1,237 | 1,566 | 591.94 | Upgrade
|
Income Tax Expense | 442.41 | 384.74 | 118.43 | 447.13 | 277.51 | 169.36 | Upgrade
|
Earnings From Continuing Operations | 780.95 | 755.48 | 296.24 | 789.79 | 1,288 | 422.58 | Upgrade
|
Minority Interest in Earnings | -91.94 | -72.33 | -24.97 | -55.36 | -115.01 | -5.61 | Upgrade
|
Net Income | 689.01 | 683.15 | 271.27 | 734.43 | 1,173 | 416.97 | Upgrade
|
Net Income to Common | 689.01 | 683.15 | 271.27 | 734.43 | 1,173 | 416.97 | Upgrade
|
Net Income Growth | 74.28% | 151.84% | -63.06% | -37.41% | 181.42% | 107.68% | Upgrade
|
Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 | 43 | Upgrade
|
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 | 43 | Upgrade
|
Shares Change (YoY) | 0.07% | - | - | - | - | - | Upgrade
|
EPS (Basic) | 15.85 | 15.72 | 6.24 | 16.90 | 27.00 | 9.59 | Upgrade
|
EPS (Diluted) | 15.85 | 15.72 | 6.24 | 16.90 | 27.00 | 9.59 | Upgrade
|
EPS Growth | 74.16% | 151.84% | -63.06% | -37.41% | 181.42% | 107.68% | Upgrade
|
Free Cash Flow | 335.51 | -1,160 | -2,861 | -1,457 | 609.77 | -326.75 | Upgrade
|
Free Cash Flow Per Share | 7.72 | -26.68 | -65.82 | -33.52 | 14.03 | -7.52 | Upgrade
|
Dividend Per Share | 3.000 | 3.000 | - | 4.167 | 8.333 | 2.778 | Upgrade
|
Dividend Growth | - | - | - | -50.00% | 200.00% | -33.33% | Upgrade
|
Gross Margin | 42.73% | 40.60% | 36.71% | 42.34% | 40.92% | 37.06% | Upgrade
|
Operating Margin | 10.59% | 10.02% | 8.28% | 13.07% | 16.22% | 8.74% | Upgrade
|
Profit Margin | 4.10% | 4.31% | 2.37% | 7.87% | 13.22% | 6.71% | Upgrade
|
Free Cash Flow Margin | 1.99% | -7.32% | -24.97% | -15.62% | 6.87% | -5.26% | Upgrade
|
EBITDA | 2,451 | 2,106 | 1,421 | 1,640 | 1,838 | 922.21 | Upgrade
|
EBITDA Margin | 14.57% | 13.28% | 12.40% | 17.58% | 20.70% | 14.85% | Upgrade
|
D&A For EBITDA | 669.7 | 517.09 | 471.85 | 420.85 | 397.99 | 378.94 | Upgrade
|
EBIT | 1,781 | 1,589 | 949.17 | 1,219 | 1,440 | 543.27 | Upgrade
|
EBIT Margin | 10.59% | 10.02% | 8.28% | 13.07% | 16.22% | 8.74% | Upgrade
|
Effective Tax Rate | 36.16% | 33.74% | 28.56% | 36.15% | 17.72% | 28.61% | Upgrade
|
Advertising Expenses | - | 712.1 | 385.33 | 301.07 | 286.53 | 147.3 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.